ticarcillin has been researched along with Disease Exacerbation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charbek, E; Rowbotham, NJ; Smith, S | 1 |
Ampofo, K; Cash, J; Chatfield, BA; Korgenski, K; Zobell, JT | 1 |
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
Jahnke, N; Remmington, T; Ryan, G | 1 |
3 review(s) available for ticarcillin and Disease Exacerbation
Article | Year |
---|---|
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Forced Expiratory Volume; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2018 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 2013 |
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cystic Fibrosis; Disease Progression; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Ticarcillin; Tobramycin | 2012 |
1 other study(ies) available for ticarcillin and Disease Exacerbation
Article | Year |
---|---|
High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acids; Creatinine; Cystic Fibrosis; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Humans; Infant; Leukocyte Count; Liver Function Tests; Platelet Count; Retrospective Studies; Ticarcillin | 2010 |